Oncocyte Membrane-Camouflaged Multi-Stimuli-Responsive Nanohybrids for Synergistic Amplification of Tumor Oxidative Stresses and Photothermal Enhanced Cancer Therapy
Source abstract
Abstract
The combination of various therapeutic modalities has received considerable attention for improving antitumor performance. Herein, an innovative nanohybrid, namely CaO2@FePt-DOX@PDA@CM (CFDPM), was developed for synergistic chemotherapy/chemodynamic therapy/Ca2+ overloading-mediated amplification of tumor oxidative stress and photothermal enhanced cancer therapy. Camouflage of the 4T1 cell membrane enabled CFDPM to escape the immune surveillance and accumulate in the tumor tissue. Ca2+, released from CaO2, could lead to mitochondrial dysfunction and facilitate the production of reactive oxygen species to amplify intracellular oxidative stress. Meanwhile, the increase of H2O2 concentration could enhance the efficiency of the chemodynamic therapy (CDT). Moreover, the hypoxic condition could be alleviated remarkably, which is attributed to the sufficient O2 supply by CaO2, resulting in the suppression of drug resistance and promotion of the chemotherapeutic effect. The nanohybrids involving Ca2+ overloading/CDT/chemotherapy could synergistically amplify the tumor oxidative stresses and remarkably aggravate the death of cancer cells. Significantly, the excellent photothermal conversion performance of CFDPM could further promote the tumoricidal effect. The in vitro and in vivo studies revealed that CFDPM could effectively advance the therapeutic efficiency via the cooperation of various therapeutic modalities to optimize their individual virtue, which would open a valuable avenue for effective cancer treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Functional Nanomaterials and Technology in Universities of Shandong, College of Chemistry and Chemical Engineering, Linyi University, Linyi 276000, China
Shandong Center for Disease Control and Prevention, Jinan 250000, China
School of Materials Science and Engineering, Linyi Universitys, Linyi 276000, China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Shandong Province · Primary Research and Development Plan of Shandong Province
References (51)
Show source-provided references
1. 10.3390/ijms2211569810.3390/ijms22115698 ↗
2. 10.1021/acs.chemrev.8b0040110.1021/acs.chemrev.8b00401 ↗
3. 10.1021/ar700108g10.1021/ar700108g ↗
4. 10.1021/acsnano.8b0099910.1021/acsnano.8b00999 ↗
5. 10.1002/anie.20140899010.1002/anie.201408990 ↗
6. 10.1021/acs.nanolett.8b0390510.1021/acs.nanolett.8b03905 ↗
7. 10.1039/D0CS00671H10.1039/D0CS00671H ↗
8. 10.1016/j.cclet.2021.10.05410.1016/j.cclet.2021.10.054 ↗
9. 10.1021/acsami.5b1252310.1021/acsami.5b12523 ↗
10. 10.1021/jm061371e10.1021/jm061371e ↗
11. 10.1038/nrd280310.1038/nrd2803 ↗
12. 10.1016/j.addr.2009.02.00510.1016/j.addr.2009.02.005 ↗
13. 10.1016/j.ccr.2006.08.01510.1016/j.ccr.2006.08.015 ↗
14. 10.1155/2017/942053910.1155/2017/9420539 ↗
15. 10.4161/cbt.7.12.706710.4161/cbt.7.12.7067 ↗
16. 10.1016/j.canlet.2008.02.04410.1016/j.canlet.2008.02.044 ↗
17. 10.1021/acsnano.1c0789310.1021/acsnano.1c07893 ↗
18. 10.1002/anie.20191511810.1002/anie.201915118 ↗
19. 10.1039/D1NJ01272J10.1039/D1NJ01272J ↗
20. 10.1038/s41467-018-05798-x10.1038/s41467-018-05798-x ↗
21. 10.1002/anie.20151003110.1002/anie.201510031 ↗
22. 10.1002/smll.20200089710.1002/smll.202000897 ↗
23. 10.1002/adfm.20210610610.1002/adfm.202106106 ↗
24. 10.1021/acsami.1c1330410.1021/acsami.1c13304 ↗
25. 10.1002/adma.20170640710.1002/adma.201706407 ↗
26. 10.1016/j.chempr.2020.02.02010.1016/j.chempr.2020.02.020 ↗
27. 10.1016/j.biomaterials.2021.12098710.1016/j.biomaterials.2021.120987 ↗
28. 10.1016/j.chempr.2019.06.00310.1016/j.chempr.2019.06.003 ↗
29. 10.1021/acsnano.1c0730810.1021/acsnano.1c07308 ↗
30. 10.1021/acsnano.8b0203410.1021/acsnano.8b02034 ↗
31. 10.7150/thno.4363110.7150/thno.43631 ↗
32. 10.1039/D1BM01303C10.1039/D1BM01303C ↗
33. 10.1002/smll.20170243110.1002/smll.201702431 ↗
34. 10.1002/adfm.20200973310.1002/adfm.202009733 ↗
35. 10.1002/anie.20201687210.1002/anie.202016872 ↗
36. 10.1021/acsami.6b1524710.1021/acsami.6b15247 ↗
37. 10.1002/adfm.20220127510.1002/adfm.202201275 ↗
38. 10.1002/adma.20200742610.1002/adma.202007426 ↗
39. 10.1002/adma.20210826310.1002/adma.202108263 ↗
40. 10.1021/acsami.0c0017010.1021/acsami.0c00170 ↗
41. 10.1021/ja108948z10.1021/ja108948z ↗
42. 10.1039/D1TB01539G10.1039/D1TB01539G ↗
43. 10.1021/acsnano.6b0469510.1021/acsnano.6b04695 ↗
44. 10.1021/acsnano.7b0253310.1021/acsnano.7b02533 ↗
45. 10.1021/acsami.9b1867610.1021/acsami.9b18676 ↗
46. 10.1016/S0162-0134(01)00422-610.1016/S0162-0134(01)00422-6 ↗
47. 10.1002/anie.20140851010.1002/anie.201408510 ↗
48. 10.1002/advs.20190213710.1002/advs.201902137 ↗
49. 10.1111/j.1471-4159.2005.03042.x10.1111/j.1471-4159.2005.03042.x ↗
50. 10.1002/adfm.20200984810.1002/adfm.202009848 ↗
51. 10.1038/sj.onc.120657610.1038/sj.onc.1206576 ↗